Read more

February 04, 2020
2 min read
Save

Depression, anxiety increased opioid use, health care costs after hip arthroscopy

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Cale Jacobs
Cale A. Jacobs

Patients with both femoroacetabular impingement and depression or anxiety had significantly greater opioid use and health care costs before and after hip arthroscopy than those who had femoroacetabular impingement alone, according to published results.

Perspective from Dean K. Matsuda, MD

Among 14,830 patients with femoroacetabular impingement (FAI) who underwent hip arthroscopy between October 2010 and December 2015, Cale A. Jacobs, PhD, of the University of Kentucky, and colleagues compared health care costs in the year before and after surgery between patients with and those without depression or anxiety. The number of patients who filled narcotic pain prescriptions within 180 days before surgery and greater than 60 or 90 days after hip arthroscopy were also compared between the groups, according to researchers.

Results showed 35.1% of patients had depression or anxiety claims before surgery. Researchers found opioid-related prescriptions were filled by a significantly greater proportion of patients with preoperative depression or anxiety in the 6 months before surgery and both greater than 60 and 90 days after surgery. Before and following surgery, patients with preoperative depression or anxiety had significantly greater health care costs, according to results.

Jacobs and colleagues noted treatment strategies that specifically target patients with FAI and comorbid mental health diagnoses need to be developed to “both improve the likelihood of a successful clinical outcome, as well as to lessen the risk of chronic opioid use and health care utilization costs.” Surgeons and health care providers should also counsel patients with depression or anxiety on the increased risk of prolonged opioid use before surgery, according to the authors.

“Because of the increased postoperative opioid use and previously reported inferior patient-reported outcomes for hip arthroscopy patients with depression or anxiety, we must partner with our mental health colleagues to improve outcomes for this at-risk patient population,” Jacobs told Healio Orthopedics. “Multidisciplinary clinical care pathways must be established that not only involve perioperative screening, but also viable treatment options for the underserved group. At the University of Kentucky, we have initiated programs involving cognitive behavioral therapy for patients with knee osteoarthritis and are working to establish similar programs for femoroacetabular impingement and orthopedic trauma patients as well.” – by Casey Tingle

 

Disclosures: Jacobs reports he receives grants from Smith & Nephew, Medtronic, Zimmer Biomet and Aesculap. Please see the study for all other authors’ relevant financial disclosures.